Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors
Ryan B. Corcoran(Massachusetts General Hospital), Geoffrey I. Shapiro(Brigham and Women's Hospital), Ryan J. Sullivan(Dana-Farber Cancer Institute), Gianluca Mauri(University of Milan), James M. Cleary(Brigham and Women's Hospital), Keith T. Flaherty(Cancer Research Center), Jennifer Veneris, Colin D. Weekes(Massachusetts General Hospital), Bryanna L. Norden(Massachusetts General Hospital), Giulia Siravegna(University of Turin), Aparna R. Parikh(Massachusetts General Hospital), Joan S. Brugge(Harvard University), Gary Chi(Harvard University), Helen X. Chen(National Cancer Institute), Leanne G. Ahronian(Harvard University), 俊彦 上田(Massachusetts General Hospital), Ursula A. Matulonis(Dana-Farber Cancer Institute), Niya Xiong(Dana-Farber Cancer Institute), Joyce F. Liu(Duke University), Rebecca S. Heist(Massachusetts General Hospital), T. Khanh(Brigham and Women's Hospital), Alexa Michel(Harvard University), Naoko Takebe(National Cancer Institute), Isobel J. Fetter(Harvard University), Dejan Juric(Massachusetts General Hospital), Jeffrey W. Clark(Massachusetts General Hospital), Richard T. Penson(Massachusetts General Hospital), Emily E. Van Seventer(Massachusetts General Hospital), Oladapo Yeku(Harvard University), Jeong Eun Kim(Asan Medical Center), Kyle Camphausen(Massachusetts General Hospital)
Cited by 39
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k